NOVT Novanta Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 44
Relative Strength: Rel. Strength: 79
Relative Valuation: Rel. Valuation: 15
Relative Profitability: Rel. Profitability: 50

EPS in 2026 (TTM): $1.4

Last Report Period Date: Apr 3, 2026

As of June this year, based on Novanta's most recent financial report, the company's trailing twelve months EPS is $1.4. During 2025, NOVT reported a per-share earnings of $1.47, which shows a decline compared to the EPS of $1.78 recorded in 2024. Novanta's EPS for the quarterly period ending on Apr 3, 2026 came in at $0.52.

NOVT earnings history

Historical annual and quarterly earnings per share (EPS) data for Novanta
EPS (TTM)
$1.4
EPS Growth YoY (Quarterly)
-11.9%
EPS (Quarterly)
$0.52
EPS Growth (Quarterly)
13%

The yearly earnings per share during 2025 was $1.47, a decline of 17.4% compared to $1.78 recorded in 2024. Over the quarter ending Apr 3, 2026, the earnings per share came in at $0.52, reflecting a 11.9% decline compared to the same quarter a year earlier. As of April 2026, the TTM EPS is $1.4. During 2024, the annual earnings per share was $1.78, representing a decrease of 12.3% compared to 2023.

NOVT earnings chart

NOVT EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-11.9%
EPS growth YoY
-17.4%
EPS growth 3Y avg
-10.9%
EPS growth 5Y avg
3%

Novanta has recorded a decline in earnings per share of 11.9% in the past 12 months (YoY, quarterly). During the past three years, NOVT registered an average yearly EPS growth of -10.9%. Novanta had an average annual EPS growth of 3% in the last five years. Over the last decade, NOVT had an average annual earnings per share growth of 3.6%.

NOVT Earnings Waterfall

Breakdown of revenue, profit and net income for Novanta

NOVT Earnings vs Peers

What are the earnings of NOVT compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
NOVT Novanta Inc 118.04 -17.4% -10.9% 3%
OBIO Orchestra BioMed Holdings Inc N/A 33.1% N/A N/A
OM Outset Medical Inc N/A 85.5% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.